Quince Therapeutics (QNCX) Q1 2025 Earnings

24MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.64
-0.47
-0.3
-0.13

Details

Expected EPS
-0.18
Actual EPS
-0.28
Surprise EPS
-0.1
Surprise Percent
+55.56%

Description

Quince Therapeutics (QNCX) has reported earnings of -0.28 per share for Q1 2025.

0 Comments

Share your thoughts